Breast cancer is a highly heterogeneous tumour and has been divided into distinct molecular subtypes as follows: luminal A/B (ER and/or PR positive), HER2 enriched (HER2 positive) and triple‐negative breast cancer (ER, PR and HER2 negative).31, 32. This evidence concerns the gene ERBB2 and neoplasm.